Gim Seow - Titan Pharmaceuticals CEO Board
| TTNP Stock | USD 3.66 0.07 1.88% |
CEO
Gim Seow is CEO Board of Titan Pharmaceuticals
| Age | 42 |
| Address | 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
| Phone | 650 244 4990 |
| Web | https://www.titanpharm.com |
Titan Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (1.7263) % which means that it has lost $1.7263 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.6899) %, meaning that it created substantial loss on money invested by shareholders. Titan Pharmaceuticals' management efficiency ratios could be used to measure how well Titan Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/20/2025, Return On Tangible Assets is likely to drop to -0.83. In addition to that, Return On Capital Employed is likely to drop to -1.32. As of 03/20/2025, Non Current Liabilities Other is likely to grow to about 1 M, while Total Current Liabilities is likely to drop slightly above 1.6 M.Similar Executives
| Found 5 records | CEO Age | ||
| Tiago MD | Pasithea Therapeutics Corp | 48 | |
| Bastiaan MSc | Lixte Biotechnology Holdings | 53 | |
| Jeffrey JD | Indaptus Therapeutics | 58 | |
| David MBA | Salarius Pharmaceuticals | 62 | |
| Adrian Gottschalk | Foghorn Therapeutics | 49 | |
Management Performance
| Return On Equity | -3.69 | ||||
| Return On Asset | -1.73 |
Titan Pharmaceuticals Leadership Team
Elected by the shareholders, the Titan Pharmaceuticals' board of directors comprises two types of representatives: Titan Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Titan. The board's role is to monitor Titan Pharmaceuticals' management team and ensure that shareholders' interests are well served. Titan Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Titan Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brian Crowley, Senior Administration | ||
| Gim Seow, CEO Board | ||
| Joe Schrei, Executive Operations | ||
| Katherine BeebeDeVarney, COO President | ||
| Weei Chay, Chief Officer | ||
| Marc MD, Ex Director | ||
| David Lazar, Principal Officer | ||
| Jennifer Kiernan, Executive Coordinator | ||
| Brynner Chiam, Acting Officer | ||
| Mike Fritz, National Director |
Titan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Titan Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.69 | ||||
| Return On Asset | -1.73 | ||||
| Current Valuation | (2.71 M) | ||||
| Shares Outstanding | 914.23 K | ||||
| Shares Owned By Insiders | 45.46 % | ||||
| Shares Owned By Institutions | 1.85 % | ||||
| Number Of Shares Shorted | 27.3 K | ||||
| Price To Earning | (3.60) X | ||||
| Price To Book | 1.06 X | ||||
| Price To Sales | 1,234 X |
Additional Tools for Titan Stock Analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.